//
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors